A semisynthetic vaccine to Streptococcus pneumoniae type 3 has been developed. The hexasaccharide [3)GlcpA,(l4)Glcp(1]3 was isolated from a partial acid hydrolysate of the capsular polysaccharide S3. It was coupled to stearylamine by reductamination with NaCNBH3 and then incorporated into liposomes. These haptenated liposomes were tested for immunogenicity in mice. They induced protection to a lethal dose (25 50% lethal doses) of S. pneumoniae type 3 and gave rise to immunoglobulin M antibodies. No cross-protection was observed against S. pneumoniae type 11.
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In 1974, a new approach for antigen presentation which involved incorporation of antigens into liposomal membranes was introduced by Kinsky and colleagues (10). Synthetic haptens were coupled to an amphipathic compound (e.g., phosphatidylethanolamine) and subsequently inserted noncovalently within a nonimmunogenic carrier (the liposomal lipid bilayers). These haptenated liposomes differ in two important respects from coventional hapten-carrier complexes in which haptens are covalently attached to immunogenic carriers such as proteins or polysaccharides.
For the development of a semisynthetic vaccine to Streptococcus pneumoniae serotype 3, an oligosaccharide served as haptenic determinant. This oligosaccharide, consisting of three
, was prepared from the bacterial capsular polysaccharide (3) (strain 2835, National Institute of Public Health, Bilthoven, The Netherlands). The latter polysaccharide consists only of repeating units of cellobiuronic acid that are P(1-3) linked to each other (4). By partial acid hydrolysis, these P(1-*3) linkages are cleaved preferentially, resulting in the formation of cellobiuronic acid oligomers (7). The above-mentioned hexasaccharide (HS) was isolated by subsequent gel filtration with Sephadex G-25 superfine gel (Pharmacia Fine Chemicals, Uppsala, Sweden) and Bio-Gel P4 (-400 mesh, Bio-Rad Laboratories, Richmond, Calif.) (4, 8) . The purity of the HS was checked by silica gel thin-layer chromatography with n-butanol-pyridine-water (6:5:5, vol/vol) and 360-MHz 1H nuclear magnetic resonance spectroscopy. In addition, gas-chromatographic sugar analysis was carried out on the corresponding HS-alditol (5, 9) (GlcA: Glc:Glc-ol, 3.0:1.8:1.0). Reductamination of the hexasaccharide (2, 12) was carried out with a fivefold molar excess of stearylamine (Polysciences Inc., Warrington, Pa.) and NaCNBH3 in tetrahydrofuran-water (30:12, vol/vol) as solvent. The reaction was allowed to proceed for 2 weeks at room temperature with magnetic stirring at pH 8. The excess of stearylamine was removed from the formed glycolipid (HS -S) by chloroform extraction. The lyophilized glycolipid was washed with methanol to remove the excess of NaCNBH3 and was subsequently dissolved in chloroform-methanol (3:1, vol/vol). The unreacted sugar component was filtered off. The coupling product of the HS and stearylamine was investigated by gas chromatographymass spectrometry after methanolysis and trimethylsilylation. Besides the trimethylsilylated methyl glycosides of glucose and glucuronic acid methyl ester, 2,3,4,5,6,-penta-O-trimethylsilyl-1-deoxy-1-N-stearylamino-D-glucitol was detected. In the total ion current chromatogram, small amounts of the palmityl and margaryl analogs were also observed. These compounds were due to impurities in the commercially available stearylamine.
Liposome preparations were actively haptenated by incorporation of the glycolipid into a basic lipid mixture containing dipalmitoyl -L-aphosphatidyl choline and cholesterol. The ratio of HS -S, dipalmotoyl L-ct-phosphatidyl choline, and cholesterol was 5:85:10. Haptenated liposomes were prepared as described previously (11).
The immunogenicity of HS -S liposomes was 
